Effect of supplementation in treatment of patients with Alzheimer's disease
Phase 2
- Conditions
- Alzheimer's disease.Dementia in Alzheimer disease
- Registration Number
- IRCT201511305623N60
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with Alzheimer's disease
Aged 60 to 95 years
Exclusion Criteria
Patients with metabolic disorders
Patients with chronic infections and/or other clinically relevant disorders
Consuming probiotic supplements within 6 weeks prior to the study
Taking other forms of probiotics including probiotic yogurt, kefir, and other fermented foods
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive function. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Mini Mental State Exam (MMSE).
- Secondary Outcome Measures
Name Time Method